ACE and heart failure: The recommendation of combining ACE inhibitors with isosorbide dinitrate and hydralazine is based on the African American Heart Failure Trial (A-HeFT), demonstrating a 4% improved survival and a 33% reduction in first HF hospitalization in HFrEF patients [35].